Australia markets open in 7 hours 37 minutes

Vivani Medical, Inc. (VANI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.21000.0000 (0.00%)
At close: 01:00PM EDT
1.2100 0.00 (0.00%)
After hours: 03:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 66.52M
Enterprise value 57.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.32
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.93

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 33.42%
S&P500 52-week change 325.51%
52-week high 37.8000
52-week low 30.8400
50-day moving average 31.6076
200-day moving average 31.3673

Share statistics

Avg vol (3-month) 3392.03k
Avg vol (10-day) 3128.82k
Shares outstanding 554.98M
Implied shares outstanding 654.98M
Float 829.81M
% held by insiders 145.54%
% held by institutions 111.16%
Shares short (14 June 2024) 41.48M
Short ratio (14 June 2024) 41.85
Short % of float (14 June 2024) 44.96%
Short % of shares outstanding (14 June 2024) 42.70%
Shares short (prior month 15 May 2024) 4680.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Jan 2020
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 319 Aug 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-33.79%
Return on equity (ttm)-75.65%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -26.24M
Net income avi to common (ttm)-25.37M
Diluted EPS (ttm)-0.5000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)29.65M
Total cash per share (mrq)0.54
Total debt (mrq)20.37M
Total debt/equity (mrq)70.96%
Current ratio (mrq)5.13
Book value per share (mrq)0.52

Cash flow statement

Operating cash flow (ttm)-21.25M
Levered free cash flow (ttm)-14.94M